Oracle priced about $20 billion in concurrent offerings on Nov. 2, 2026, split roughly evenly between common stock and senior notes, according to its pricing announcement. Oracle said each offering was expected to close on Nov. 4, subject to customary conditions, and that either could close independently.
Oracle priced 86 million shares at $116 each
The stock offering covered 86,206,897 common shares at $116 per share. Oracle estimated net proceeds of about $9.9 billion after underwriting discounts and estimated offering expenses. The note sale was the other half of the financing, with about $10 billion in principal.
Five note tranches carry coupons from 7% to 8.65%
Oracle priced five fixed-rate note series totaling $10 billion. A coupon is the stated interest rate on a note; its maturity is the year principal is due. Oracle estimated net proceeds from the notes at about $10.0 billion.
| Principal amount | Annual coupon | Maturity |
| $2.00 billion | 7.000% | 2029 |
| $1.75 billion | 7.450% | 2031 |
| $2.25 billion | 7.850% | 2033 |
| $2.50 billion | 8.000% | 2037 |
| $1.50 billion | 8.650% | 2046 |
The notes are unsecured senior obligations of Oracle Corporation. The prospectus says they rank equally with the company’s other unsecured, unsubordinated debt and are effectively subordinated to liabilities of Oracle subsidiaries and to secured debt. Oracle’s prospectus supplement also reported $236.1 billion in consolidated liabilities, including $125.3 billion in senior unsecured borrowings, as of Aug. 31, 2026. For more balance-sheet context, see NeoTeo’s earlier breakdown of Oracle’s borrowings.
Oracle described the proceeds as general corporate funding
Oracle said proceeds could support general corporate purposes, including capital expenditures, debt repayment, investments or acquisitions, dividends, and share repurchases. Reuters reported that Oracle had committed to seeking no more than $20 billion in additional AI financing through fiscal 2030; CNBC reported that this offering matched the amount outlined at an investor event. Oracle’s stated uses for the proceeds remain broad.
Reports put Oracle’s Nov. 2 share decline at different levels
Reuters reported a 3.5% decline in premarket trading on Nov. 2. CNBC later reported an 8.8% session decline, while The Next Web reported an 8.6% decline for the session.
